Sputnik-V Vaccine To Be Available In India from May, RDIF Plans To Manufacture Russian Vaccines On A Large Scale
New Delhi, 15th April 2021: The emergency use of the third vaccine was also recently approved in India, with the Coronavirus growing in number.
The Russian-made Corona vaccine Sputnik V is likely to be imported into India next month. As far as its production in India is concerned, it may take until June or July.
Kirill Dimitri, CEO of the Russian Direct Investment Fund (RDIF), said vaccines manufacturing in India could begin in late June or early July through various local tie-ups.
Dr Reddy’s Labs, which has a license to distribute the vaccine, on Tuesday, received the Drug Controller of India approval for the import of the vaccine under restricted use in an emergency.
In addition to a partnership with Dr Reddy’s Labs, which is conducting Sputnik V clinical trials locally and which has distribution rights for Russian vaccines i.e. RDIF has talked with five other local companies for production. Those companies are Stellis Biopharma, Gland Pharma, Hetero Biopharma, Panacea Biotech, and Virchow Biotech.
India will produce at least five crore doses of Sputnik V in the next few months. Kirill Dimitri said, “We are seeing a production of five crore doses of Sputnik V in India this summer or by the end of the summer. India has a significant production capacity. We have already launched a large-scale production of Sputnik V we have announced tie-ups with five local companies. We intend to do many more tie-ups which will be announced soon.”
He said, “Sputnik V testing in India has shown a high level of the immune response. We have got the same results not only in Russia but also in Argentina, Mexico, and other countries where the vaccine is being used. Sputnik V provides a high degree of protection. Sputnik is more than 90% effective.”
